Literature DB >> 16793172

Quantification of human angiotensinogen by a novel sandwich ELISA.

Yuki Suzaki1, Yuri Ozawa, Hiroyuki Kobori.   

Abstract

The urinary angiotensinogen excretion rates show a clear relationship to kidney angiotensin II content, suggesting that urinary angiotensinogen may serve as an index of angiotensin II-dependent hypertensive rats. However, simple and accurate methods to measure human angiotensinogen are unavailable at this time. We have developed two antibodies and a sensitive and specific quantification ELISA system for human angiotensinogen to be applicable to human subjects. The ELISA is able to detect human angiotensinogen at range of 0.01-1 microg/well (R(2)=0.9945) using standard ELISA plates. This ELISA will be a useful tool to investigate the relationship between urinary angiotensinogen excretion rates and reactivity to antihypertensive drugs in hypertensive human subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793172      PMCID: PMC1995000          DOI: 10.1016/j.peptides.2006.05.006

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  15 in total

1.  Review: Intrarenal angiotensin II levels in normal and hypertensive states.

Authors:  L Gabriel Navar; Kenneth D Mitchell; Lisa M Harrison-Bernard; Hiroyuki Kobori; Akira Nishiyama
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2001-03       Impact factor: 1.636

2.  Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats.

Authors:  G Mazzocchi; L K Malendowicz; A Markowska; G Albertin; G G Nussdorfer
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-06       Impact factor: 4.310

3.  Vascular angiotensin-converting enzyme expression regulates local angiotensin II.

Authors:  D N Müller; J Bohlender; K F Hilgers; D Dragun; O Costerousse; J Ménard; F C Luft
Journal:  Hypertension       Date:  1997-01       Impact factor: 10.190

4.  Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.

Authors:  D J Campbell; A C Lawrence; A Towrie; A Kladis; A J Valentijn
Journal:  Hypertension       Date:  1991-12       Impact factor: 10.190

5.  Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

Review 6.  Regulation of intrarenal angiotensin II in hypertension.

Authors:  L Gabriel Navar; Lisa M Harrison-Bernard; Akira Nishiyama; Hiroyuki Kobori
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

7.  Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.

Authors:  L J Dell'Italia; Q C Meng; E Balcells; C C Wei; R Palmer; G R Hageman; J Durand; G H Hankes; S Oparil
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

8.  Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

Review 9.  Intrarenal angiotensin II and hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa Prieto-Carrasquero
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

10.  AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Minolfa C Prieto-Carrasquero; Yuri Ozawa; L Gabriel Navar
Journal:  Hypertension       Date:  2004-03-22       Impact factor: 10.190

View more
  8 in total

Review 1.  The importance of the intrarenal renin-angiotensin system.

Authors:  Juan Carlos Q Velez
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-09

2.  Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.

Authors:  Yoshio Konishi; Akira Nishiyama; Takashi Morikawa; Chizuko Kitabayashi; Mikiko Shibata; Masahiro Hamada; Masatsugu Kishida; Hirofumi Hitomi; Hideyasu Kiyomoto; Takenori Miyashita; Nozomu Mori; Maki Urushihara; Hiroyuki Kobori; Masahito Imanishi
Journal:  Hypertension       Date:  2011-06-13       Impact factor: 10.190

3.  Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure.

Authors:  Casey M Rebholz; Jing Chen; Qi Zhao; Ji-Chun Chen; Jianxin Li; Jie Cao; Luis Gabriel Navar; Lotuce Lee Hamm; Dongfeng Gu; Jiang He
Journal:  J Hypertens       Date:  2015-07       Impact factor: 4.844

4.  Young Scholars Award Lecture: Intratubular angiotensinogen in hypertension and kidney diseases.

Authors:  Hiroyuki Kobori; Yuri Ozawa; Yuki Suzaki; Minolfa C Prieto-Carrasquero; Akira Nishiyama; Tatsuya Shoji; Eric P Cohen; L Gabriel Navar
Journal:  Am J Hypertens       Date:  2006-05       Impact factor: 2.689

5.  Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients.

Authors:  Hiroyuki Kobori; Akemi Katsurada; Yuri Ozawa; Ryousuke Satou; Kayoko Miyata; Naoki Hase; Yuki Suzaki; Tatsuya Shoji
Journal:  Biochem Biophys Res Commun       Date:  2007-04-26       Impact factor: 3.575

6.  Glomerular angiotensinogen protein is enhanced in pediatric IgA nephropathy.

Authors:  Masanori Takamatsu; Maki Urushihara; Shuji Kondo; Maki Shimizu; Tetsuo Morioka; Takashi Oite; Hiroyuki Kobori; Shoji Kagami
Journal:  Pediatr Nephrol       Date:  2008-04-18       Impact factor: 3.651

7.  Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin-angiotensin-aldosterone and dopaminergic systems in acute phase of ARB therapy.

Authors:  Yukako Isobe-Sasaki; Michio Fukuda; Yoshiaki Ogiyama; Ryo Sato; Toshiyuki Miura; Daisuke Fuwa; Masashi Mizuno; Tetsuhei Matsuoka; Hiroko Shibata; Hiroyuki Ito; Minamo Ono; Sumiko Abe-Dohmae; Ken Kiyono; Yoshiharu Yamamoto; Hiroyuki Kobori; Makoto Michikawa; Junichiro Hayano; Nobuyuki Ohte
Journal:  Physiol Rep       Date:  2017-06

8.  Addition of hydrochlorothiazide to angiotensin receptor blocker therapy can achieve a lower sodium balance with no acceleration of intrarenal renin angiotensin system in patients with chronic kidney disease.

Authors:  Daisuke Fuwa; Michio Fukuda; Yoshiaki Ogiyama; Ryo Sato; Masashi Mizuno; Toshiyuki Miura; Sumiko Abe-Dohmae; Makoto Michikawa; Hiroyuki Kobori; Nobuyuki Ohte
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-06-09       Impact factor: 1.636

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.